FRENCH DRUG AGENCY SLAMS ROGER BELLON

26 June 1994

France's government pharmaceutical authority has criticized the manufacturer Roger Bellon (a subsidiary of Rhone-Poulenc Rorer) for issuing a televised warning regarding product contamination before informing health care professionals.

The agency says that Bellon's decision to tell the public via television about a cyanide-contaminated flask containing its antibiotic Josacine (josamycin), which has caused a young girl's death, had provoked a panic. The agency itself was alerted late in the day, and had been unable to launch the usual procedure followed in such cases.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight